14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
I. EXEMPTIONS - Resale Exemption - Domokur Aviation Services, LLC v. McClain, Ohio BTA Case No. 20...
Read More >
Last week, the U.S. Equal Employment Opportunity Commission (EEOC) issued its FY 2019 Performance Re...
Read More >
With effect from 6 April 2020, medium and large organisations in the private sector will become resp...
Read More >
Consider the following provision of in a contract between a general contractor and a subcontractor.....
Read More >
It’s the end of the year and while everyone is busy, employers in California should be aware of new...
Read More >
As 2019 comes to an end, we are pleased to present our traditional End of Year Plan Sponsor “To Do”...
Read More >